Impaired adenosine monophosphate kinase (AMPK) signalling under hyperglycaemic
conditions is known to cause mitochondrial dysfunction in diabetic sensory neurons …

Recent studies have demonstrated brain insulin signaling impairment and mitochondrial
dysfunction in diabetes. Hyperinsulinemia and hyperlipidemia arising from diabetes have …

Adenosine monophosphate-activated protein kinase (AMPK) has been studied for its myriad
metabolic and mitochondrial benefits in several chronic diseases. Recent studies have …

Mitochondrial dysfunction occurs in sensory neurons and may contribute to distal
axonopathy in animal models of diabetic neuropathy. The adenosine monophosphate …

Diabetic peripheral neuropathy (DPN) is a long-term complication of diabetes with a
complicated pathogenesis. AMP-activated protein kinase (AMPK) senses oxidative stress …

Diabetic neuropathy is a neurological complication of diabetes that causes significant
morbidity and, because of the obesity-driven rise in incidence of type 2 diabetes, is …

Diabetic neuropathy is a dying back neurodegenerative disease of the peripheral nervous
system where mitochondrial dysfunction has been implicated as an etiological factor …

Diabetic neuropathy is a major complication of diabetes that results in the progressive
deterioration of the sensory nervous system. Mitochondrial dysfunction has been proposed …

Enhancement of ischemic brain damage is one of the most serious complications of
diabetes. Studies from various in vivo and in vitro models of cerebral ischemia have led to …

Diabetic peripheral neuropathy (DPN) is a progressive neurodegenerative disease of
peripheral nervous system with high energy requirement. The adenosine monophosphate …